Bausch + Lomb : Will Acquire XIIDRA®
Bausch + Lomb Will Acquire XIIDRA® Acquisition Represents Significant Opportunity for Growth in Prescription Dry Eye Segment VAUGHAN,...
Source: marketscreener.com
Stay updated with breaking news from Lomb Forward Looking. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bausch + Lomb Will Acquire XIIDRA® Acquisition Represents Significant Opportunity for Growth in Prescription Dry Eye Segment VAUGHAN,...